HypoxaMIRs: Key Regulators of Hallmarks of Colorectal Cancer

Cells. 2022 Jun 11;11(12):1895. doi: 10.3390/cells11121895.

Abstract

Hypoxia in cancer is a thoroughly studied phenomenon, and the logical cause of the reduction in oxygen tension is tumor growth itself. While sustained hypoxia leads to death by necrosis in cells, there is an exquisitely regulated mechanism that rescues hypoxic cells from their fatal fate. The accumulation in the cytoplasm of the transcription factor HIF-1α, which, under normoxic conditions, is marked for degradation by a group of oxygen-sensing proteins known as prolyl hydroxylases (PHDs) in association with the von Hippel-Lindau anti-oncogene (VHL) is critical for the cell, as it regulates different mechanisms through the genes it induces. A group of microRNAs whose expression is regulated by HIF, collectively called hypoxaMIRs, have been recognized. In this review, we deal with the hypoxaMIRs that have been shown to be expressed in colorectal cancer. Subsequently, using data mining, we analyze a panel of hypoxaMIRs expressed in both normal and tumor tissues obtained from TCGA. Finally, we assess the impact of these hypoxaMIRs on cancer hallmarks through their target genes.

Keywords: HIF-1α; angiogenesis; hypoxaMIR; metastasis; miRNA network; miRNA regulation; microRNAs; transcription factor.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Hypoxia
  • Colorectal Neoplasms* / genetics
  • Humans
  • Hypoxia
  • Oxygen / metabolism
  • Transcription Factors / genetics
  • Von Hippel-Lindau Tumor Suppressor Protein* / genetics

Substances

  • Transcription Factors
  • Von Hippel-Lindau Tumor Suppressor Protein
  • Oxygen

Grants and funding

This research was funded by Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico, Grant Programa Presupuestal F003, proyecto CF 2019/51207. J. Coronel-Hernández received the catedratic support COMECYT EDOMÉX CAT2021-0024.